ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 249 filers reported holding ACADIA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.57 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $4,457,000 | -85.0% | 316,293 | -74.2% | 0.01% | -79.5% |
Q1 2022 | $29,717,000 | -8.7% | 1,226,971 | -12.0% | 0.04% | 0.0% |
Q4 2021 | $32,556,000 | +36.8% | 1,394,839 | -2.7% | 0.04% | +34.5% |
Q3 2021 | $23,801,000 | -32.4% | 1,432,958 | -0.8% | 0.03% | -31.0% |
Q2 2021 | $35,224,000 | -12.4% | 1,444,182 | -7.3% | 0.04% | -17.6% |
Q1 2021 | $40,191,000 | -44.7% | 1,557,800 | +14.7% | 0.05% | -42.7% |
Q4 2020 | $72,634,000 | +76.6% | 1,358,670 | +36.3% | 0.09% | +53.4% |
Q3 2020 | $41,124,000 | -36.1% | 996,942 | -25.0% | 0.06% | -43.7% |
Q2 2020 | $64,403,000 | +20.6% | 1,328,709 | +5.1% | 0.10% | -9.6% |
Q1 2020 | $53,411,000 | -4.2% | 1,264,168 | -3.0% | 0.11% | +16.3% |
Q4 2019 | $55,765,000 | +0.1% | 1,303,540 | -15.7% | 0.10% | -6.7% |
Q3 2019 | $55,684,000 | +34.0% | 1,547,205 | -0.5% | 0.10% | +36.4% |
Q2 2019 | $41,556,000 | +36.7% | 1,554,658 | +37.4% | 0.08% | +28.3% |
Q1 2019 | $30,390,000 | +644.3% | 1,131,829 | +348.2% | 0.06% | +566.7% |
Q4 2018 | $4,083,000 | – | 252,518 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Baker Brothers Advisors | 27,228,338 | $611,821,000 | 5.19% |
First Washington CORP | 176,950 | $3,976,000 | 2.06% |
SECTORAL ASSET MANAGEMENT INC | 783,424 | $17,604,000 | 1.93% |
HARVEY CAPITAL MANAGEMENT INC | 219,042 | $4,921,000 | 1.84% |
Ghost Tree Capital, LLC | 400,000 | $8,988,000 | 1.82% |
Opus Point Partners Management, LLC | 36,733 | $825,000 | 1.62% |
Palo Alto Investors LP | 1,650,780 | $37,093,000 | 1.59% |
EMORY UNIVERSITY | 84,714 | $1,904,000 | 1.36% |
GARRISON BRADFORD & ASSOCIATES INC | 69,000 | $1,550,000 | 1.32% |
HealthCor Management, L.P. | 1,378,000 | $30,964,000 | 1.05% |